Secor Capital Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Secor Capital Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-40,540	Closed	-$685K	–	582
2017 Q2	$685K	Buy	40,540 +5,313	+15%	+$80.9K	0.06%	313
2017 Q1	$470K	Buy	+35,227	New	+$552K	0.05%	351
2016 Q4	–	Sell	-92,242	Closed	-$1.08M	–	669
2016 Q3	$1.08M	Buy	+92,242	New	+$1.08M	0.12%	243
2015 Q4	–	Sell	-22,456	Closed	-$369K	–	680
2015 Q3	$369K	Buy	22,456 +2,169	+11%	+$44.4K	0.12%	298
2015 Q2	$463K	Buy	+20,287	New	+$404K	0.17%	228
2014 Q2	–	Sell	-18,269	Closed	-$213K	–	343
2014 Q1	$213K	Buy	18,269 +556	+3%	+$9.41K	0.1%	262
2013 Q4	$313K	Buy	+17,713	New	+$298K	0.12%	253

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Secor Capital Advisors's MNTA Position: Q3 2017 in Review

Secor Capital Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 40,540 shares — an estimated $685K sold.

Secor Capital Advisors first reported a position in MNTA in Q4 2013 and held it in 7 quarters. The position peaked at $1.08M in Q3 2016. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

Secor Capital Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
Secor Capital Advisors sold 40,540 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $685K.
Secor Capital Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 7 quarters.
Secor Capital Advisors's Momenta Pharmaceuticals, Inc. position peaked at $1.08M in Q3 2016.
158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Secor Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.